Wednesday, July 8, 2026

pharma · Postoperative Pain · Pain · PCRX

Pacira Ireland

Pacira Ireland is a pharma organization headquartered in Ranelagh, IE. It trades on NYSE under ticker PCRX. Primary therapeutic focus areas include Postoperative Pain, Pain, Postoperative Pain Management, Osteoarthritis,

Ranelagh, IE HQ
2007 Founded
7 Employees
Public company Type
PCRX · NYSE Ticker
Company details
Status
Public
HQ
Ranelagh, IE
Founded
2007
Employees
7
Programs
100
Drugs
32
Patents
57
Clinical program

Liposomal Bupivacaine Infiltration

Approved · small molecule · Postoperative Pain

Liposomal Bupivacaine Infiltration for Postoperative Pain is a Approved program (small_molecule) at Pacira Ireland Limited with 1 ClinicalTrials.gov record(s).

← All Pacira Ireland Limited projects Approved small molecule terminated

Internal code HP-00054364

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Pacira Ireland Limited
Phase
Approved
Modality
small_molecule
Indication
Postoperative Pain
Status
terminated
Trials
1